SCHEMBL28825622

SCHEMBL28825622

FC(F)(F)c1ccc([CH]c2cccc(C(F)(F)F)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.56
FBP1 P09467 1/20 0.49
TTR P02766 1/20 0.46
PIM1 P11309 1/20 0.46
CISD1 Q9NZ45 1/20 0.46
PIM2 Q9P1W9 1/20 0.46
TSHR P16473 2/20 0.45
MAPK1 P28482 1/20 0.45
ALDH1A1 P00352 1/20 0.44
MEN1 O00255 2/20 0.43
MAPT P10636 2/20 0.43
KMT2A Q03164 2/20 0.43
AHR P35869 1/20 0.43
PTGS1 P23219 1/20 0.43
P4HB P07237 1/20 0.43
LMNA P02545 1/20 0.43
HSP90AA1 P07900 1/20 0.43
PKM P14618 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3237563 0.92 NFE2L2 (0.58) NFE2L2FBP1TTRPIM1CISD1
SCHEMBL7435417 0.90 NFE2L2 (0.53) NFE2L2FBP1TTRPIM1CISD1
SCHEMBL6205431 0.87 NFE2L2 (0.51) NFE2L2FBP1TTRPIM1CISD1
SCHEMBL1981457 0.83 ALDH1A1 (0.59) FBP1TSHRALDH1A1AHRPTGS1
SCHEMBL2096662 0.82 CYP1A2 (0.52) FBP1TSHRALDH1A1AHRPTGS1
SCHEMBL13790316 0.79 NFE2L2 (0.82) NFE2L2FBP1TTRPIM1CISD1
SCHEMBL28825569 0.78 NFE2L2 (0.46) NFE2L2FBP1TTRPIM1CISD1
SCHEMBL28825568 0.78 NFE2L2 (0.46) NFE2L2FBP1TTRPIM1CISD1
SCHEMBL8718176 0.78 TSHR (0.63) NFE2L2TSHRMAPK1ALDH1A1MAPT
SCHEMBL543252 0.77 NFE2L2 (0.56) NFE2L2FBP1TTRPIM1CISD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114007610-A Substituted heteroaromatic pyrazolopyridines and their use as modulators of the GLUN2B receptor 詹森药业有限公司 2022-02-01 CN disclosed